WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY

Edo Savelkoul  1     Remi Mahmoud  2     Dirk De Jong  2     Willemijn Van Dop  2     Tessa E.H. Römkens  3     Loes Nissen  3     Nofel Mahmmod  4     Petra van Boeckel  5     Maurice Lutgens  6     Wout Mares  7     Ludger S.M. Epping Stippel  8     Itta Minderhoud  9     Jeroen Michiel Jansen  10     Ingrid Gisbertz  11     Paul Boekema  12     Daan De Koning  13     Carmen Horjus Talabur Horje  14     Bindia Jharap  15     Bas Oldenburg  15     Frank Hoentjen  16    
1 Radboudumc, Nijmegen, Netherlands
2 University Medical Center Utrecht, Utrecht, Netherlands
3 Jeroen Bosch Hospital, Den Bosch, Netherlands
4 Antonius Ziekenhuis, Zeist, Netherlands
5 Antonius Ziekenhuis, Nieuwegein, Netherlands
6 Elisabeth-TweeSteden Hospital, Tilburg, Netherlands
7 Hospital Gelderse Vallei, Ede, Netherlands
8 Maasziekenhuis Pantein, Boxmeer, Netherlands
9 Tergooi Medical Centre, Hilversum, Netherlands
10 Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
11 Bernhoven Hospital, Uden, Netherlands
12 Maxima Medical Centre, Veldhoven, Netherlands
13 Gelre Hospital, Apeldoorn, Netherlands
14 Rijnstate Hospital, Arnhem, Netherlands
15 Meander Medical Centre, Amersfoort, Netherlands
16 University of Alberta, Edmonton, Canada

Topic
IBD, Nurses

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing